Kyntra Bio, Inc. (KYNB)
NASDAQ · Manufacturing · Pharmaceutical preparations
$6.90−$0.1000 (−1.43%) on the dayAs of the close; data may be delayed.
KYNB price, last 12 months
Key stats
- Previous close
- $7.00
- Open
- $7.01
- Day range
- $6.90 – $7.01
- 52-week range
- $6.32 – $9.70
- Volume
- 18.9K
- Avg volume (20 days)
- 26.4K
- Market cap
- $28.1M
Performance
1W−2.5%
1M−14.9%
3M−4.7%
6M+5.5%
YTD—
1Y—
Technicals and fundamentals
About Kyntra Bio, Inc.
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $28.1M